Collecting Data From Prostate Cancer Patients Treated With Focal One
Part of Cancer, Kidney & urinary clinical trials.
This study gathers information from patients who are being treated for prostate cancer using a machine called Focal One, which uses focused ultrasound to target cancer cells. The goal is to collect real-world data about how the treatment works and its effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being treated for prostate cancer using the Focal One device
- You are willing to have your clinical data collected and stored in a registry
- You have not been deprived of liberty by a court or government decision
- You are not under legal guardianship or curatorship (unless your country's rules don't require this)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry for people who have already had focal therapy (targeted treatment) for prostate cancer at Queen Mary Hospital. It aims to collect information about these treatments, which may help improve future care.
This registry tracks men with early-stage prostate cancer who choose focal therapy—a targeted treatment that destroys only the cancer area while preserving healthy prostate tissue. The study helps doctors understand how well this approach works and its safety.
This study is tracking men who choose focal therapy (a targeted treatment) for their localized prostate cancer. It aims to learn how well this treatment works and how it affects quality of life.
This is a registry study for men with intermediate-risk prostate cancer who are getting a type of focal treatment (treating only the cancer spot, not the whole prostate). It collects data on treatments like HIFU, cryotherapy, and others to better understand their long-term results.
This trial tests if a focused ultrasound treatment can safely and effectively treat prostate cancer that has come back after radiation therapy. The ultrasound uses sound waves to heat and destroy cancer cells in a specific area of the prostate while sparing healthy tissue.
This study looks at outcomes after “focal therapy,” a type of treatment that targets only part of the prostate, for people with newly diagnosed or returning prostate cancer. It may help researchers understand how well this targeted approach works and for whom.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.